Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Alternatives in Class At a glance Brand Vyvanse (30-day supply) / $350 to $450 cash price Generic lisdexamfetamine (30-day supply) / $30 to $80 cash price (since August 2023) Generic mixed amphetamine salts XR / $15 to $50 per month Generic methylphenidate ER / $20 to $45 per month FDA-approved indications / ADHD (ages 6+) and binge eating disorder (adults) Duration of action / 12 to 13 hours in controlled trials DEA schedule / Schedule II controlled substance Prodrug conversion / Lisdexamfetamine is cleaved to d-amphetamine in red blood cells Patent expiration / August 2023 (first generics launched) Insurance tier / Tier 2 to 3 for generics
Patients with diabetes should be aware that rapid improvement in blood glucose can temporarily worsen diabetic retinopathy in those with pre-existing retinopathy, necessitating appropriate eye care follow-up
BPC-157 legal status and TB-500 India -regulations around peptides vary
Included Peptides BPC-157 A synthetic pentadecapeptide studied in laboratory research for its role in peptide-mediated signaling pathways and intracellular regulatory processes
